Volpara’s software enables the early detection of breast cancer and the company’s mission is that “no woman should die from breast cancer”.
They have announced that RadNet, based in Los Angeles, will implement Volpara software throughout its organisation. Volpara Analytic’s artificial intelligence will consistently manage mammography quality across RadNet’s 350+ sites.
Volpara Risk Pathways will be used to ensure RadNet patients have access to essential imaging and genetic testing. RadNet is the largest provider of outpatient imaging services in the US.
Volpara Group CEO, Teri Thomas said: “Volpara is pleased to partner with such a large and well-respected organisation as RadNet. Together we will save even more families from cancer”.